Ten-year follow-up study of allergen-specific immunoglobulin E and immunoglobulin G4, soluble interleukin-2 receptor, interleukin-4, soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in serum of patients on immunotherapy for perennial allergic rhinitis

Scandinavian Journal of Immunology

Volumn 47, Issue 2, 1998, Pages 167-178

  Ohashi, Y ^a   Nakai, Y ^a   Tanaka, A ^a   Kakinoki, Y ^a   Washio, Y ^a   Kato, A ^a   Masamoto, T ^a   Sakamoto, H ^a   Yamada, K ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; MONOCLONAL ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHAGOIDES FARINAE; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; PRIORITY JOURNAL; SERUM;

ADOLESCENT; ADULT; ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOTHERAPY; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-4; MALE; MIDDLE AGED; MITES; PROSPECTIVE STUDIES; RECEPTORS, INTERLEUKIN-2; RHINITIS, ALLERGIC, PERENNIAL; SOLUBILITY; TIME FACTORS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0031890517     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00278.x     Document Type: Article

References (43)

1. Ewan PW, Alexander MM, Snape C et al. Effective hyposensitization in allergic rhinitis using a potent partially purified extract of house dust mite. Clin Allergy 1988;18:501-8.
2. Corrado ID, Pastorello E, Ollier S et al. A double-blind study of hyposensitization with an alginate conjugated extract of D. pteronyssinus (Conjuvac®) in patients with perennial rhinitis. 1. Clinical aspects. Allergy 1989;44:108-15.
3. McHugh SM, Lavelle B, Kemeny DM et al. A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pternonyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses. J Allergy Clin Immunol 1990;86:521-32.
4. Nakagawa T, Kozeki H, Katagiri J et al. Changes of house dust mite-specific IgE, IgG and IgG subclass antibodies during immunotherapy in patients with perennial rhinitis. Int Arch Allergy Appl Immun 1987;82:95-9.
5. Ohashi Y, Nakai Y, Okamoto H et al. Significant correlation between symptom score and IgG4 antibody titer following long-term immunotherapy for perennial allergic rhinitis. Ann Otol Rhinol Laryngol 1997;106:483-9.
6. Djurup R, Malling HJ. High IgG4 antibody level is associated with failure of IT with inhalant allergens. Clin Allergy 1987;17:459-68.
7. Bousquet J, Hejjaoui A, Michel FB. Specific immunotherapy in asthma. J Allergy Clin Immunol 1990;86:292-305.
8. Ricci M, Rossi O, Bertoni M, Matucci A. The importance of TH-2-like cells in the pathogenesis of airway allergic inflammation. Clin Exp Allergy 1993;23:360-9.
9. Varney VA, Hamid QA, Gaga M et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993;92:644-51.
10. Ohashi Y, Nakai Y, Sakamoto H et al. Serum level of interleukin-4 in patients with perennial allergic rhinitis during allergen-specific immunotherapy. Scand J Immunol 1996;43:680-6.
11. Ohashi Y, Nakai Y, Sakamoto H et al. Serum levels of soluble interleukin-2 receptor in patients with perennial allergic rhinitis before and after immunotherapy. Ann Allergy Asthma Immunol 1996;77:203-8.
12. Ohashi Y, Nakai Y, Tanaka A et al. Soluble intercellular adhesion molecule-1 level in sera is elevated in perennial allergic rhinitis. Laryngoscope 1997;107:932-5.
13. Okuda M, Ishikawa T, Saito Y et al. A clinical evaluation of N′-5 with perennial-type allergic rhinitis. A test by multi-clinic, intergroup, doubleblind comparative method. Ann Allergy 1984;53:178-85.
14. 41st World Medical Assembly. Declaration of Helsinki: recommendations guiding physicians in biomedical research involving human subjects. Bull Pan Am Health Organ 1990;24:606-9.
15. Boccagni P, Favari F, Zanoni G. Comparison of four in vitro assays for specific IgE detection. Int J Clin Lav Res 1994;24:102-5.
16. Chilosi M, Semenzato G, Cetto G et al. Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant α-interferon therapy on clinical parameters and natural killer in vitro activity. Blood 1987;70:1530-5.
17. Ohashi Y, Nakai Y, Kakinoki Y et al. Immunotherapy affects the seasonal increase in specific IgE and interleukin-4 in the serum of patients with seasonal allergic rhinitis. Scand J Immunol 1997;46:67-77.
18. Nakagawa T, de Weck AL. Membrane receptors for the IgG4 subclass on human basophils and mast cells. Clin Rev Allergy 1983;1:197-206.
19. Stanworth DR, Smith AK. Inhibition of reagin-mediated PCA reactions in baboons by the human IgG4 sub-class. Clin Allergy 1973;3:37-41.
20. Kay AB. T lymphocytes and their products in atopic allergy and asthma. Int Arch Allergy Appl Immunol 1991;94:189-93.
21. Finkelman FD, Holmes J, Katona HM et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990;8:303-33.
22. Lopez AF, Sanderson CJ, Gamble JR et al. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J Exp Med 1988;167:219-24.
23. Schleimer RP, Sterbinsky SA, Kaiser J et al. Interleukin-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J Immunol 1992;148:1086-92.
24. Tsai LC, Hung MW, Tang RB. Changes of serum-specific IgE antibody titer during hyposensitization in mite-sensitive asthmatic children. J Asthma 1990;27:95-100.
25. Clyton WF, Reisman RE, Georgitis JW et al. Effect of prolonged venom immunotherapy on serum venom-specific IgE and IgG. Clin Allergy 1983;13:301-7.
26. Ohashi Y, Nakai Y, Kihara S et al. House dust mite-specific IgE, IgG1, and IgG4 antibodies in patients with perennial rhinitis. Ann Otol Rhinol Laryngol 1987;96:434-7.
27. Robb RJ, Munck A, Smith KA. T cell growth factor receptors. Quantitation, specificity and biological relevance. J Exp Med 1981;154:1455-74.
28. Rubin LA, Kurman CC, Fritz ME et al. Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985;135:3172-7.
29. Pui CH. Serum interleukin-2 receptor: clinical and biological implications. Leukemia 1989;3:323-34.
30. Matsumoto T, Miike T, Yamaguchi K et al. Serum levels of soluble IL-2 receptor, IL-4 and IgE-binding factors in childhood allergic diseases. Clin Exp Immunol 1991;85:288-92.
31. Prete GD, Maggi E, Parronchi P et al. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988;140:4193-8.
32. Finkelman FD, Holmes J, Katona HM et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990;8:303-33.
33. Abehsira-Amar O, Gilbert M, Joliy M et al. IL-4 plays a dominant role in the differential development of TH0 into TH1 and TH2 cells. J Immunol 1992;148:3820-9.
34. Vercelli D, Jahara HH, Arai K et al. Endogenous IL-6 plays an obligatory role in IL-4 induced human IgE synthesis. Eur J Immunol 1989;19:1419-24.
35. Puunonen J, Aversa G, Cocks BG et al. Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression. Proc Natl Acad Sci USA 1993;90:3730-4.
36. + lymphocytes in atopic subjects with elevated serum IgE concentrations. Ann Allergy 1992;69:131-4.
37. Montefort S, Feather IH, Wilson SJ et al. The expression of leucocyte-endothelial adhesion molecules is increased in perennial allergic rhinitis. Am J Respir Cell Biol 1992;7:393-8.
38. Wegner CD, Gundel RH, Reilly P et al. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990;247:416-8.
39. Chihara J, Yamamoto T, Kurachi D, Nakajima S. Soluble ICAM-1 in sputum of patients with bronchial asthma. Lancet 1994;343:1108.
40. Ohashi Y, Nakai Y, Tanaka A et al. Soluble vascular cell adhesion molecule-1 in perennial allergic rhinitis. Acta Otolaryngol (Stockh) (in press).
41. Bochner BS, Luscinskas FW, Gimbrone MA et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin-1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 1991;173:1553-7.
42. Nakajima H, Sano H, Nishimura T, Yoshida S, Iwamoto I. Role of vascular cell adhesion molecule-1/very late activation antigen 4 and intercellular adhesion molecule-1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J Exp Med 1994;179:1145-54.
43. Ohashi Y, Nakai Y, Ikeoka H et al. Increased ciliary beating frequency of nasal mucosa following immunotherapy for allergy. Ann Otol Rhinol Laryngol 1989;98:350-4.